search
Longevity.Technology
Trends
- 1
Biotech company Basecamp has raised $140 million to develop artificial intelligence trained on biological data. The funding, reported by Longevity.Technology, is aimed at teaching AI systems the whole of biology, with potential applications in drug discovery and longevity research. Details on the investors and how the capital will be deployed have not yet been fully disclosed.